NO153568C - Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater.

Info

Publication number
NO153568C
NO153568C NO813138A NO813138A NO153568C NO 153568 C NO153568 C NO 153568C NO 813138 A NO813138 A NO 813138A NO 813138 A NO813138 A NO 813138A NO 153568 C NO153568 C NO 153568C
Authority
NO
Norway
Prior art keywords
preparation
physiologically active
amidino
amidine derivatives
analogy procedure
Prior art date
Application number
NO813138A
Other languages
English (en)
Norwegian (no)
Other versions
NO813138L (no
NO153568B (no
Inventor
Setsuro Fujii
Toshiyuki Okutome
Toyoo Nakayama
Takashi Yaegashi
Masateru Kurumi
Original Assignee
Torii & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12826980A external-priority patent/JPS5753454A/ja
Priority claimed from JP6494281A external-priority patent/JPS57179146A/ja
Application filed by Torii & Co Ltd filed Critical Torii & Co Ltd
Publication of NO813138L publication Critical patent/NO813138L/no
Publication of NO153568B publication Critical patent/NO153568B/no
Publication of NO153568C publication Critical patent/NO153568C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Power Steering Mechanism (AREA)
  • Medicinal Preparation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
NO813138A 1980-09-16 1981-09-15 Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater. NO153568C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12826980A JPS5753454A (en) 1980-09-16 1980-09-16 Guanidinobenzoate and anticomplementary agent
JP6494281A JPS57179146A (en) 1981-04-28 1981-04-28 Amidine compound

Publications (3)

Publication Number Publication Date
NO813138L NO813138L (no) 1982-03-17
NO153568B NO153568B (no) 1986-01-06
NO153568C true NO153568C (no) 1986-05-21

Family

ID=26406084

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813138A NO153568C (no) 1980-09-16 1981-09-15 Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater.

Country Status (17)

Country Link
US (2) US4454338A (da)
EP (1) EP0048433B1 (da)
KR (1) KR860000264B1 (da)
AT (1) ATE20051T1 (da)
AU (1) AU527371B2 (da)
CA (1) CA1177488A (da)
CS (1) CS228534B2 (da)
DD (1) DD201779A5 (da)
DE (1) DE3174717D1 (da)
DK (1) DK155003C (da)
ES (1) ES8206443A1 (da)
FI (1) FI73975C (da)
GB (1) GB2083818B (da)
HU (1) HU185956B (da)
NO (1) NO153568C (da)
PH (1) PH18109A (da)
SU (1) SU1176832A3 (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
GB2095239B (en) * 1981-02-27 1985-03-06 Torii & Co Ltd Novel amidine compounds
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
JPS59139357A (ja) * 1983-01-28 1984-08-10 Torii Yakuhin Kk アミジン誘導体
US4818273A (en) * 1983-11-14 1989-04-04 The Dow Chemical Company Substituted 1,2,4-triazolo[1,5-a]pyrimidine-2-sulfonamides, compositions containing them, and their utility as herbicides
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
GB2162171B (en) * 1984-07-26 1988-01-27 Torii & Co Ltd Amidine compounds
FR2568253B1 (fr) * 1984-07-26 1987-01-30 Torii Co Nouvelle amidine
DE3427865A1 (de) * 1984-07-27 1986-02-06 Torii & Co., Tokio/Tokyo Amidinoverbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
US4709082A (en) * 1984-10-25 1987-11-24 Nissan Chemical Industries, Ltd. 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof
US4873253A (en) * 1987-03-30 1989-10-10 Shosuke Okamoto Phenylalanine derivative and proteinase inhibitor
US4990537A (en) * 1988-07-11 1991-02-05 Banyu Pharmaceutical Co., Ltd. Anti influenza agent
US5116985A (en) * 1989-12-28 1992-05-26 Snow Brand Milk Products Co., Ltd. Isoquinoline derivatives and salts thereof
ATE119523T1 (de) * 1989-12-28 1995-03-15 Snow Brand Milk Products Co Ltd Isochinolinderivate und ihre salze als proteasehemmer.
US5238964A (en) * 1990-04-05 1993-08-24 Torii & Co., Ltd. Agent for treatment of cerebrovascular contraction
JPH078789B2 (ja) * 1990-04-05 1995-02-01 鳥居薬品株式会社 脳血管攣縮治療剤
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
ATE178589T1 (de) * 1994-09-20 1999-04-15 Ono Pharmaceutical Co Amidinophenol-derivate als protease-hemmende verbindungen
DE69529770T2 (de) * 1994-12-02 2003-12-24 Yamanouchi Pharmaceutical Co., Ltd. Neues amidinonaphthylderivat oder dessen salz
KR100258496B1 (ko) * 1995-01-05 2000-06-15 쓰까다 후미끼 치환아미디노나프틸에스테르유도체
US6388122B1 (en) 1996-04-10 2002-05-14 Ono Pharmaceutical Co., Ltd. Tryptase inhibitor and novel guanidino derivatives
US6653340B1 (en) 1997-06-03 2003-11-25 Biocryst Pharmaceuticals, Inc. Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
WO1999024407A1 (en) * 1997-11-10 1999-05-20 Array Biopharma, Inc. Compounds which inhibit tryptase activity
US6066673A (en) 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors
EP1063973B1 (en) 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
EP1066272A4 (en) * 1998-03-27 2002-03-13 Biocryst Pharm Inc NEW CONNECTIONS USEFUL IN THE COMPLEMENT, COAGULATE AND KALLIKREIN REACTION WAY AND METHOD FOR THEIR PRODUCTION
AU3620099A (en) * 1998-04-24 1999-11-16 Proteus Molecular Design Limited Aminomethyl-benzoic ester derivatives as tryptase inhibitors
US6362216B1 (en) 1998-10-27 2002-03-26 Array Biopharma Inc. Compounds which inhibit tryptase activity
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および/または線溶系酵素阻害剤との組み合わせからなる医薬
JP5204947B2 (ja) * 2002-11-27 2013-06-05 ディーエムアイ バイオサイエンシズ インコーポレイテッド リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
US20050192348A1 (en) * 2003-09-25 2005-09-01 David Bar-Or Methods and products which utilize N-acyl-L-aspartic acid
EP1884237B1 (en) * 2005-05-17 2010-12-08 Santen Pharmaceutical Co., Ltd. Amidino derivatives for use in the prevention or treatment of glaucoma
EP1884236B1 (en) * 2005-05-17 2011-03-02 Santen Pharmaceutical Co., Ltd. Angiogenesis inhibitor containing amine derivative as active ingredient
GB2445920A (en) * 2007-01-25 2008-07-30 Mucokinetica Ltd Amidino compounds for treatment of respiratory disease
EP2311810A4 (en) * 2008-07-11 2012-04-04 Ajinomoto Kk AMIDINE DERIVATIVE
US8802681B2 (en) 2008-10-17 2014-08-12 Signature Therapeutics, Inc. Pharmaceutical compositions with attenuated release of phenolic opioids
BR112012005124B1 (pt) 2009-09-08 2021-11-09 Signature Therapeutics, Inc. Pro-fármaco de opioide modificado por cetona, seu método de preparação, sua composição farmacêutica, sua unidade de dose, métodos e usos
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
US20110262355A1 (en) 2010-04-21 2011-10-27 Jenkins Thomas E Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
US9238020B2 (en) 2010-04-21 2016-01-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
CN103153288B (zh) 2010-07-09 2017-02-15 詹姆斯·特林卡·格林 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统
ES2584634T3 (es) 2011-01-11 2016-09-28 Signature Therapeutics, Inc. Composiciones que comprenden un profármaco de oxicodona escindible enzimáticamente
WO2012096886A1 (en) 2011-01-11 2012-07-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable oxycodone prodrug
WO2012122420A2 (en) 2011-03-09 2012-09-13 Pharmacofore, Inc. Opioid prodrugs with heterocyclic linkers
AU2012225337B2 (en) 2011-03-09 2016-04-28 Signature Therapeutics, Inc. Active agent prodrugs with heterocyclic linkers
CN103796992B (zh) 2011-09-15 2016-04-27 安斯泰来制药株式会社 胍基苯甲酸化合物
CN103012214A (zh) * 2011-09-28 2013-04-03 南京长澳医药科技有限公司 一种萘莫司他盐酸盐及萘莫司他甲磺酸盐的制备方法
AU2014230583B2 (en) * 2013-03-13 2017-09-28 Takeda Pharmaceutical Company Limited Guanidinobenzoic acid ester compound
CN103641749B (zh) * 2013-12-02 2016-02-10 山东永泰化工有限公司 一种甲磺酸萘莫司他的制备方法
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN110330447B (zh) * 2019-07-16 2022-04-15 北京赛升药业股份有限公司 一种甲磺酸萘莫司他中间体的制备方法及其应用
WO2021147272A1 (zh) * 2020-01-21 2021-07-29 中国人民解放军军事科学院军事医学研究院 苯甲酸酯类化合物在治疗SARS-CoV-2感染方面的应用
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN111574409A (zh) * 2020-05-14 2020-08-25 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) 一种甲磺酸萘莫司他的重结晶工艺方法
US12599578B2 (en) 2021-03-09 2026-04-14 Ensysce Biosciences Inc. Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.
CN113999145B (zh) * 2021-11-12 2023-02-03 开封明仁药业有限公司 一种甲磺酸萘莫司他的合成方法
AU2022422584A1 (en) 2021-12-23 2024-05-30 Subintro Limited Novel antiviral compositions comprising oleic acid
WO2023148783A1 (en) * 2022-02-07 2023-08-10 Council Of Scientific & Industrial Research Process for the preparation of nafamostat, camostat and their derivatives
CN118439976A (zh) * 2024-04-25 2024-08-06 南京海纳医药科技股份有限公司 一种甲磺酸萘莫司他晶型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD89611A (da) *
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
GB1472700A (en) * 1974-11-01 1977-05-04 Ono Pharmaceutical Co Guanidinobehzoic acid derivatives and process for preparing the same
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine

Also Published As

Publication number Publication date
EP0048433B1 (en) 1986-05-28
GB2083818B (en) 1984-05-10
EP0048433A2 (en) 1982-03-31
DK155003B (da) 1989-01-23
HU185956B (en) 1985-04-28
KR830007527A (ko) 1983-10-21
AU7506281A (en) 1982-03-25
PH18109A (en) 1985-03-22
KR860000264B1 (ko) 1986-03-22
DK410681A (da) 1982-03-17
DD201779A5 (de) 1983-08-10
CS228534B2 (en) 1984-05-14
AU527371B2 (en) 1983-03-03
EP0048433A3 (en) 1982-07-21
CA1177488A (en) 1984-11-06
ATE20051T1 (de) 1986-06-15
FI73975C (fi) 1987-12-10
DK155003C (da) 1989-05-29
FI812876L (fi) 1982-03-17
SU1176832A3 (ru) 1985-08-30
ES505460A0 (es) 1982-08-16
DE3174717D1 (en) 1986-07-03
US4532255A (en) 1985-07-30
NO813138L (no) 1982-03-17
US4454338A (en) 1984-06-12
NO153568B (no) 1986-01-06
FI73975B (fi) 1987-08-31
GB2083818A (en) 1982-03-31
ES8206443A1 (es) 1982-08-16

Similar Documents

Publication Publication Date Title
NO153568C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater.
IE781878L (en) Imidazole derivatives
DE59310197D1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
EP0326307A3 (en) Novel pyridazinone derivatives and pharmaceutical preparations containing them
GB1497857A (en) Araliphatic ketones and secondary alcohols
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
ES413153A1 (es) Un procedimiento para la preparacion de anilino benzotia- zoles.
WO1990003172A3 (en) Bile acids for treatment of viral infections
IE780279L (en) Imidazole derivatives
GB1470747A (en) Pyridazine derivative
FR2439181A1 (fr) Peptides apparentes a la somatostatine et leur utilisation therapeutique
MY101822A (en) (5r,6s,8r)-6-(1-hydroxyethyl)-2-(3r-pyrrolidin-2-one-3-yl-)thiopenem-3-carboxylic acid.
GB1232780A (da)
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
JPS5261286A (en) Preparation of enzymes
JPS5424847A (en) Optical active methionine-mandelic acid complex and its preparation
GB1202110A (en) Novel quinoline derivatives and their preparation
JPS5432482A (en) 3,4-dihydrocarbostyril derivatives and bactericides containing the same as active agnet for agricultural and horticultural uses
JPS5356662A (en) Thio lactams and process for preparation of the same
JPS5430165A (en) 2-allylamino-5-phenyloxazoles and their pharmaceutically acceptable aicd salts
IE780849L (en) Thienamycin derivatives
JPS5432473A (en) Antibiotics pseudomonic acid derivative and its preparation